Product Information
TEGRETOL XR 400 MG TABLET is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $6.4954 per EA under NDC 00078051205. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the carbamazepine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
400 mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078051205
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBAMAZEPINEApproval Type
New Drug (NDA)
FDA Application
NDA020234On Market Since
3/25/1996
Pharmacological Classes
Price Statistics
The NADAC for TEGRETOL XR 400 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 150.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.4954 per EA |
|---|---|
| All-time high | $6.5149 (Jun 10, 2026) |
| All-time low | $2.5762 (Dec 18, 2013) |
| 52-week high | $6.5149 |
| 52-week low | $6.3074 |
| Median price | $5.1953 |
| Average price | $5.0036 |
| Largest weekly change | +14.9% (Jan 15, 2014) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 91% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEGRETOL XR 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TEGRETOL XR 400 MG TABLET, manufactured by Novartis Pharmaceuticals Corporation, is $6.4954 per EA (NDC 00078051205), effective Jun 24, 2026.
How has the price of TEGRETOL XR 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for TEGRETOL XR 400 MG TABLET has risen 150.1%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TEGRETOL XR 400 MG TABLET?
Since Nov 28, 2013, the NADAC for TEGRETOL XR 400 MG TABLET has ranged from a low of $2.5762 (Dec 18, 2013) to a high of $6.5149 (Jun 10, 2026), with a median of $5.1953 per EA.
Are there cheaper alternatives to TEGRETOL XR 400 MG TABLET?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CARBAMAZEPINE ER 400 MG TABLET, is $0.6070 per EA — about 91% below TEGRETOL XR 400 MG TABLET.
Who manufactures TEGRETOL XR 400 MG TABLET?
TEGRETOL XR 400 MG TABLET (NDC 00078051205) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification